Currency in USD
Earnings Estimate | Current Qtr. (Dec 2022) | Next Qtr. (Mar 2023) | Current Year (2022) | Next Year (2023) |
---|
No. of Analysts | 3 | 3 | 3 | 3 |
Avg. Estimate | -0.64 | -0.14 | -3.45 | -0.38 |
Low Estimate | -0.78 | -0.18 | -3.61 | -0.5 |
High Estimate | -0.52 | -0.08 | -3.32 | -0.2 |
Year Ago EPS | -0.75 | -0.81 | -2.75 | -3.45 |
Revenue Estimate | Current Qtr. (Dec 2022) | Next Qtr. (Mar 2023) | Current Year (2022) | Next Year (2023) |
---|
No. of Analysts | 3 | 4 | 3 | 4 |
Avg. Estimate | 14.07M | 12.23M | 48.47M | 58.29M |
Low Estimate | 14M | 10.8M | 48.4M | 51M |
High Estimate | 14.2M | 13.01M | 48.6M | 61M |
Year Ago Sales | 12.41M | 10.17M | 39.19M | 48.47M |
Sales Growth (year/est) | 13.40% | 20.30% | 23.70% | 20.30% |
Earnings History | 12/30/2021 | 3/30/2022 | 6/29/2022 | 9/29/2022 |
---|
EPS Est. | -0.62 | -0.68 | -0.62 | -0.84 |
EPS Actual | -0.75 | -0.81 | -0.91 | -1.1 |
Difference | -0.13 | -0.13 | -0.29 | -0.26 |
Surprise % | -21.00% | -19.10% | -46.80% | -31.00% |
EPS Trend | Current Qtr. (Dec 2022) | Next Qtr. (Mar 2023) | Current Year (2022) | Next Year (2023) |
---|
Current Estimate | -0.64 | -0.14 | -3.45 | -0.38 |
7 Days Ago | -0.64 | -0.14 | -3.45 | -0.38 |
30 Days Ago | -0.64 | -0.14 | -3.45 | -0.38 |
60 Days Ago | -0.6 | -0.37 | -3.4 | -1.03 |
90 Days Ago | -0.62 | -0.55 | -3.42 | -1.5 |
EPS Revisions | Current Qtr. (Dec 2022) | Next Qtr. (Mar 2023) | Current Year (2022) | Next Year (2023) |
---|
Up Last 7 Days | N/A | N/A | N/A | N/A |
Up Last 30 Days | N/A | N/A | N/A | N/A |
Down Last 7 Days | N/A | N/A | N/A | N/A |
Down Last 30 Days | N/A | N/A | N/A | N/A |
Growth Estimates | BIOL | Industry | Sector(s) | S&P 500 |
---|
Current Qtr. | 14.70% | N/A | N/A | N/A |
Next Qtr. | 82.70% | N/A | N/A | N/A |
Current Year | -25.50% | N/A | N/A | N/A |
Next Year | 89.00% | N/A | N/A | N/A |
Next 5 Years (per annum) | 20.00% | N/A | N/A | N/A |
Past 5 Years (per annum) | 13.59% | N/A | N/A | N/A |